Square Season Brings Experiential Programming to Drexel Square April–October
Developer Brandywine marks opening of park seen as first step toward big Schuylkill Yards project
Brandywine CEO Jerry Sweeney joined Philadelphia officials including Mayor Kenney to unveil the 1.3-acre Drexel Square park.
Spark CEO Marrazzo: Philadelphia will shine at BIO 2019
Jeff Marrazzo of Spark Therapeutics says Philadelphia can maximize our gene therapy momentum.
CSL Behring CEO: No better setting for BIO 2019 than Philadelphia
At BIO 2019, it’s all about scientific breakthroughs, innovative medicines, and helping patients overcome serious diseases.
Updating an old newspaper building for Philadelphia’s new Schuylkill Yards innovation district
The Bulletin Building is a special part of West Philadelphia, so it will become a central piece of Schuylkill Yards.
As construction starts at Philly’s Schuylkill Yards, New York’s Hudson Yards serves as a cautionary tale
The future is here. Three buildings will be under construction at Schuylkill Yards by the year’s end.
All the Details on Philly’s Newest Rooftop Destination, Opening Today
Sunset Social is now serving up burgers, brews, and spectacular views from Cira Green.
Drexel hits top rank for research institutions
Drexel has joined Temple and Penn in obtaining prestigious R1 status, the highest level a research university can reach in the key higher education classification system.
Head to Cira Green, one of the most instagrammable places in Philly
It's official - take one for the 'gram
Roche to buy Spark Therapeutics for $4.8 billion
Swiss drug maker Roche entered into a definitive agreement Monday to acquire Philadelphia gene therapy pioneer Spark Therapeutics